| 000 | 01718 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515021927.0 | ||
| 264 | 0 | _c20061130 | |
| 008 | 200611s 0 0 eng d | ||
| 022 | _a0006-3126 | ||
| 024 | 7 |
_a10.1159/000092518 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeruelle, Philippe | |
| 245 | 0 | 0 |
_aBAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats. _h[electronic resource] |
| 260 |
_bBiology of the neonate _c2006 |
||
| 300 |
_a135-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGuanylate Cyclase _xmetabolism |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 |
_aHypertrophy, Right Ventricular _xpathology |
| 650 | 0 | 4 |
_aHypoxia _xcomplications |
| 650 | 0 | 4 |
_aLung _xblood supply |
| 650 | 0 | 4 | _aOrgan Size |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aBalasubramaniam, Vivek | |
| 700 | 1 | _aKunig, Anette M | |
| 700 | 1 | _aSeedorf, Gregory J | |
| 700 | 1 | _aMarkham, Neil E | |
| 700 | 1 | _aAbman, Steven H | |
| 773 | 0 |
_tBiology of the neonate _gvol. 90 _gno. 2 _gp. 135-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000092518 _zAvailable from publisher's website |
| 999 |
_c16188799 _d16188799 |
||